Formulated curcumin prevents paclitaxel-induced peripheral neuropathy through reduction in neuroinflammation by modulation of 7 nicotinic acetylcholine receptors

HIGHLIGHTS

  • who: Martial Caillaud et al. from the Department of Pharmacology and Toxicology, Translational Research Initiative for Pain and Neuropathy, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA have published the paper: Formulated Curcumin Prevents Paclitaxel-Induced Peripheral Neuropathy through Reduction in Neuroinflammation by Modulation of 7 Nicotinic Acetylcholine Receptors, in the Journal: Pharmaceutics 2022, 1296 of /2022/
  • what: The authors investigated, for the first time, the therapeutic effect of curcumin in the treatment of PIPN, using either unformulated curcumin or Meriva. For the first time, the authors show in_vivo that the anti . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?